Showing 121-130 of 224 results for "".
Exploring Hydrochlorothiazide Use and Skin Cancer Risk
https://practicaldermatology.com/topics/skin-cancer-photoprotection/exploring-hydrochlorothiazide-use-and-skin-cancer-risk/20446/A commonly used antihypertensive appears to be linked to an increased risk of SCC. What should dermatologists do?Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20533/Wishful Thinking: Looking to the Year Ahead
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/wishful-thinking-looking-to-the-year-ahead/23435/Cosmetic Surgery Forum faculty share resolutions for 2021.Eczema Discovery; Ortho Dermatologics, Revision, Alastin Product Launches
https://practicaldermatology.com/topics/practice-management/dermwiretv-eczema-discovery-ortho-dermatologics-revision-alastin-product-launches/18353/Regeneron revealed that Dupixent generated sales of $120M within the first nine months of launch. Researchers have identified a possible treatment for moderate-to-severe atopic dermatitis: IL-22 blockade. Product launches or updates from Revision Skincare, Alastin Skincare, Ortho Dermatologics, andRecent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20813/Dermatologists Give AI A Thumbs Up
https://practicaldermatology.com/topics/practice-management/dermatologists-give-ai-a-thumbs-up/23673/Dr. Vishal Patel talks augmented intelligence and how it may change practice.Therapeutics Focus: Hair and Nails
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/therapeutics-focus-hair-and-nails/20473/Smoothing Out Our Understanding of Moisturizers
https://practicaldermatology.com/topics/skin-cancer-photoprotection/smoothing-out-our-understanding-of-moisturizers/20688/New science and new approaches for dry skin.An Alternative Pathway to ABMS Maintenance of Certification (MOC)
https://practicaldermatology.com/topics/practice-management/an-alternative-pathway-to-abms-maintenance-of-certification-moc/21014/MOC concerns have spread across specialties. Here's a review of the history of MOC and the current controversy.DermWireTV: Noble Educates on Self-Injection; AAD and DEF Meeting Updates
https://practicaldermatology.com/topics/practice-management/dermwiretv-noble-educates-on-self-injection-aad-and-def-meeting-updates/19645/Participants in a study by the company Noble show that the vast majority of patients—92%—would prefer to bring home a training device to practice with prior to starting self-injection. Noble creates trainers for autoinjectors intended to increase patient confidence and autonomy with self-managed tre